This recording shows an overall review of RsNLME using Pirana and an extensive explanation on how to use RsNLME from the command line. The recording also shows the new reporting capabilities with ModelResults and VPC Results added with RsNLME 1.1.
Reduce time to completion while providing consistency across your batches of patient safety narratives Managing your patient narrative projects with moving timelines is challenging, especially given the complexities that go into preparing your data for use. With the patient narrative building features in Certara’s Synchrogenix™ Writer, you can manage thousands of patient safety narratives to … Continued
Are you utilizing a 21 CFR Part 11 compliant repository for your SAS, R, & Python data? Certara Integral data repository is designed to be a 21 CFR Part 11 compliance bolt-on solution to your existing statistical computing environment. This means Integral is compatible with your cloud-based and on-premise computing environments and is agnostic to … Continued
Developing interactive and easy-to-use stakeholder engagement content market access, medical affairs, and sales field teams is a time-consuming, expensive, and often decentralized process. BaseCase is “no-code” platform that enables you to visualize large complex datasets and economic models, which demonstrates the value of products to key decision-makers.
Meet Rachel Bombara, Sr. Regulatory Operations Specialist at Certara. In this brief video Rachel shares how she manages tight deadlines and how she leverages technology to support her daily submission work.
The pharmaceutical has made massive investments in complex biologics, a drug class that includes oligonucleotide therapeutics, immuno-oncology therapies, vaccines, antibody-drug conjugates, bispecific antibodies, and cell and gene therapies. These drugs can be challenging to develop for multiple reasons. Certara provides strategic approaches needed to optimize dosing, trial designs, payer plans, and regulatory strategy.
Vaccines are one of the greatest medical innovations. Worldwide, millions of lives are saved every year due to vaccines, which reduce disease, disability, and death from infectious diseases. Regulatory-approved vaccines go through rigorous clinical testing to show that they are safe and effective. We can all do our part by getting vaccinated. So when you … Continued
As seen on CNBC** Certara is the global leader in biosimulation, a powerful and proven technology. We transform traditional drug development by helping our customers create safe and effective medicines, faster. Certara (CERT) is proudly listed on Nasdaq.
承認申請用の薬物動態 (PK) 関連の提出書類の一環として行うCDISCドメインの作成は、多くの時間を必要とする上にエラーが発生しやすい作業です。当社のPK Submitは、この非常に負担の大きな作業を自動化します。PK Submitは、承認申請に向けて完成されたパッケージを、薬物動態モデルに依存しない解析方法（non-compartmental analysis：NCA）の設定および実行過程の中でわずか数分で自動的に作成します。
Children, the elderly, pregnant women, and other different populations may need different medication and vaccine doses to optimize safety and efficacy. But using conventional clinical trials to determine dosing for different populations can be difficult for ethical and logistical reasons. Virtual patients that vary physiologically can be used to understand how new vaccines and medicines … Continued
